Amgen has leased a 240,000-sf research facility located on the Gateway of Pacific campus in South San Francisco, Calif. Amgen will occupy the entire north tower, which is being constructed by BioMed Realty as part of the second phase of development at the site. Featuring modular wet and molecular labs designed for optimal energy efficiency, the facility will accommodate Amgen's research programs in oncology, inflammation, and cardiometabolic diseases. Offering flexible floor plates with integrated lab and office functions, the nine-story tower will include conference spaces, collaboration areas, an amenity hub, and a customizable R&D center. LEED sustainable design certification will be sought for the facility, which is slated for occupancy in early 2022.
